MedTrace Logo

DHA Proof-of-Concept Study in Infants and Toddlers

NCT05266677 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-07-18

No results posted yet for this study

Summary

This is a prospective, double blind, randomized, controlled proof-of-concept study with a parallel group design that aims to investigate the effect of a liquid oral supplement comprising a blend of glycerides at certain proportions on infant and toddler DHA status.

Conditions

  • Infants
  • Toddlers
  • Nutritional Supplement

Interventions

OTHER

blend of glycerides at certain proportions

combination of glycerides in specific proportions in a liquid oral supplement

OTHER

glycerides used in current formulas

glycerides used in current formulas in a liquid oral supplement

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Elvira M Estorninos, MD · Las Pinas Doctors Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
14 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-03-31
Completion
2023-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05266677 on ClinicalTrials.gov